Showing results (211-220 of 556) with videos related to

Sort By:
Pageof 56
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|July 24, 2008
Minimum diagnostic criteria for plasmablastic lymphoma of oral/sinonasal region encountered in a tertiary cancer hospital of a developing countryShubhada Kane, Aditi Khurana, Gorakh Parulkar, et al.
Journal of Immunotherapy and Precision Oncology|January 15, 2025
Usefulness of Comprehensive Genomic Profiling in Clinical Decision-Making in Oncology: A Systematic ReviewSewanti Limaye, Jayesh Deshmukh, Nitesh Rohatagi, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|September 7, 2021
Oral and dental health status in patients undergoing neoadjuvant chemotherapy for locally advanced head and neck cancerKanchan P Dholam, Madhura R Sharma, Sandeep V Gurav, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 24, 2005
Bone metastases from primary hepatocellular carcinoma simulating multiple myelomaDinesh Chandra Doval, Komal Bhatia, Ashok Kumar Vaid, et al.
European Journal of Medicinal Chemistry|July 30, 2010
Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivativesVijay Patil, Kalpana Tilekar, Sonali Mehendale-Munj, et al.
Oncology|July 28, 2016
Preoperative Chemotherapy and Metronomic Scheduling of Chemotherapy in Locally Advanced Oral CancersVijay M Patil, Vanita Noronha, Amit Joshi, et al.
The International Journal of Cardiovascular Imaging|September 23, 2025
Incidence and predictors of acute pulmonary embolism in patients with cancer referred for computed tomography pulmonary angiographyAmit Janu, Suyash Kulkarni, Amit Joshi, et al.
Pediatric Blood & Cancer|September 1, 2020
Increased toxicities in children with Burkitt lymphoma treated with rituximab: Experience from a tertiary cancer center in IndiaShyam Srinivasan, Nirmalya Roy Moulik, Anand Kc, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority TrialVanita Noronha, Amit Joshi, Vijay Maruti Patil, et al.
Pageof 56